BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11794846)

  • 1. Intensive treatment with lithium carbonate "once a day" in bipolar patients.
    Tondo L; Tagliamonte A; Ghiani C; Mercenaro S
    Clin Ter; 2001; 152(5):277-80. PubMed ID: 11794846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel slow-release formulation of lithium carbonate (Carbolithium Once-A-Day) vs. standard Carbolithium: a comparative pharmacokinetic study.
    Castrogiovanni P
    Clin Ter; 2002; 153(2):107-15. PubMed ID: 12078335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term efficacy and tolerability of carbolithium once a day: an interim analysis at 6 months.
    Durbano F; Mencacci C; Dorigo D; Riva M; Buffa G
    Clin Ter; 2002; 153(3):161-6. PubMed ID: 12161976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of lithium in the elderly.
    Hardy BG; Shulman KI; Mackenzie SE; Kutcher SP; Silverberg JD
    J Clin Psychopharmacol; 1987 Jun; 7(3):153-8. PubMed ID: 3110219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
    Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
    J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients.
    Rosa AR; Marco M; Fachel JM; Kapczinski F; Stein AT; Barros HM
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):217-24. PubMed ID: 16982121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does lithium dose prediction improve treatment efficiency? Prospective evaluation of a mathematical method.
    Markoff RA; King M
    J Clin Psychopharmacol; 1992 Oct; 12(5):305-8. PubMed ID: 1479047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mood stabilizer loading versus titration in acute mania: audit of clinical practice.
    Wheeler A; Robinson G; Fraser A
    Aust N Z J Psychiatry; 2008 Nov; 42(11):955-62. PubMed ID: 18941960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective clinical evaluation of an equation to predict daily lithium dose.
    Cummings MA; Haviland MG; Wareham JG; Fontana LA
    J Clin Psychiatry; 1993 Feb; 54(2):55-8. PubMed ID: 8444821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erythrocyte/plasma ratio of lithium. Determination method and individual stability].
    Barthelmebs M; Ehrhardt JD; Schweitzer-Ehret A; Danion JM; Imbs JL
    Encephale; 1993; 19(4):321-7. PubMed ID: 8275919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of lithium in plasma and red blood cells in acute and chronic intoxicated patients.
    Ferron G; Debray M; Buneaux F; Baud FJ; Scherrmann JM
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):351-5. PubMed ID: 7582387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Overcoming resistance to lithium prophylaxis].
    Soucek K
    Cesk Psychiatr; 1991 Apr; 87(2):73-5. PubMed ID: 1913949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate.
    Berrettini WH; Nurnberger JI; Hare TA; Simmons-Alling S; Gershon ES; Post RM
    Biol Psychiatry; 1983 Feb; 18(2):185-94. PubMed ID: 6403063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal variation in plasma levels of lithium in the Indian population: is there a need to modify the dose?
    Medhi B; Prakash O; Jose VM; Pradhan B; Chakrabarty S; Pandhi P
    Singapore Med J; 2008 Sep; 49(9):724-7. PubMed ID: 18830549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in hypothyroidism between lithium-free and -treated patients with bipolar disorders.
    Zhang ZJ; Qiang Li ; Kang WH; Tan QR; Gao CG; Zhang FG; Wang HH; Ma XC; Ce Chen ; Wei Wang ; Li Guo ; Zhang YH; Yang XB; Zhang RG
    Life Sci; 2006 Jan; 78(7):771-6. PubMed ID: 16137715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study.
    Biel MG; Peselow E; Mulcare L; Case BG; Fieve R
    Bipolar Disord; 2007 Aug; 9(5):435-42. PubMed ID: 17680913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled lithium discontinuation in bipolar patients with good response to long-term lithium prophylaxis.
    Yazici O; Kora K; Polat A; Saylan M
    J Affect Disord; 2004 Jun; 80(2-3):269-71. PubMed ID: 15207941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the Cockcroft-Gault method to estimate lithium dosage requirement.
    Chiu CC; Shen WW; Chen KP; Lu ML
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):269-74. PubMed ID: 17472595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.